Research review
Does acidophilus help with skin disease? What the research does and doesn't show
People search whether acidophilus helps rosacea, eczema, seborrheic dermatitis or acne. The named-strain trials that exist tested narrow populations and specific forms — and for rosacea and seborrheic dermatitis, no trial exists at all.
The evidence doesn't support acidophilus, on its own, as a treatment for rosacea, seborrheic dermatitis or acne — no trial has tested it for either of the first two. The trials that exist looked at eczema and atopic dermatitis, using specific named strains and blends in narrow populations, not general skin health.
What the evidence doesn't support
It doesn't support acidophilus as a treatment for rosacea. This review found no trial — of any size or quality — testing a Lactobacillus acidophilus strain, alone or in a blend, in people with rosacea. The same is true for seborrheic dermatitis, including on the vulva specifically: that's a narrower, location-specific question with no dedicated trial behind it, whatever a search result might imply.
Where trials do exist — for eczema and atopic dermatitis, and for acne — they tested named strains, heat-killed material or multi-species blends, not "acidophilus" as a generic category. A capsule labeled simply "acidophilus" isn't necessarily the same organism, in the same form, at the same dose, as the one a given trial used. Probiotic effects are documented to be strain-specific, and a result from one named strain doesn't automatically transfer to another.
What the trials found
A randomized, double-blind, placebo-controlled trial gave 112 pregnant women with a family history of allergic disease a once-daily probiotic mix — Bifidobacterium bifidum BGN4, B. lactis AD011 and Lactobacillus acidophilus AD031 — or placebo, starting 4 to 8 weeks before delivery and continuing to 6 months after birth; the published abstract doesn't state a CFU dose. Sixty-eight infants completed follow-up to age 1. Eczema had occurred in 18.2% of the probiotic group's infants by then, versus 40.0% of the placebo group's (p = 0.048). This tested prevention in infants already considered at risk, using a three-strain blend given to mothers and babies — not a single acidophilus strain taken by an adult who already has a skin condition.
A 2014 double-blind, placebo-controlled trial in 49 Japanese adults (16 and older) with atopic dermatitis tested heat-killed Lactobacillus acidophilus L-92, taken daily for 8 weeks; the abstract doesn't state a CFU-equivalent dose. SCORAD, the standard severity index, was lower in the L-92 group than in controls after 8 weeks (p = 0.002), and eosinophil counts and one inflammatory marker shifted in the same direction. Heat-killed material is a different form from the live cultures most acidophilus supplements sell — the organism was inactivated before use.
A follow-up 2016 trial extended the comparison to 24 weeks in 50 adults with atopic dermatitis, using the same heat-killed, dried L-92 strain against placebo. Investigator ratings, the EASI score and SCORAD were all lower in the L-92 group by the end of the trial, and the study reported no adverse events in either group.
A 2013 open-label trial randomized 45 women, ages 18 to 35, with mild-to-moderate acne into three groups for 12 weeks: an oral probiotic blend alone — Lactobacillus acidophilus (5 billion CFU/capsule), L. bulgaricus (5 billion CFU/capsule) and Bifidobacterium bifidum (20 billion CFU/capsule), two capsules a day, per the trial's published protocol — the antibiotic minocycline alone, or both together. Total lesion counts changed from baseline in all three groups over the 12 weeks. The trial had no placebo-only arm, so there's no way to separate what the probiotic-alone group's change owed to the probiotic from what it owed to time, expectation or the natural course of mild acne. Two of the 45 participants, both in the minocycline-only group, stopped early because of a yeast infection.
| Trial | Population | Form / dose | Duration | What it measured |
|---|---|---|---|---|
| Eczema prevention | 112 pregnant women + infants at family risk | 3-strain blend incl. L. acidophilus AD031; dose not reported | Prenatal to 6 mo. postnatal; infants followed to 1 yr | Eczema by age 1: 18.2% vs 40.0% |
| Adult atopic dermatitis (I) | 49 adults, 16+ | Heat-killed L-92; dose not reported | 8 weeks | SCORAD lower than placebo |
| Adult atopic dermatitis (II) | 50 adults, 16+ | Heat-killed L-92; dose not reported | 24 weeks | IGA, EASI, SCORAD lower than placebo |
| Acne, open-label | 45 women, 18–35 | L. acidophilus 5B CFU + 2 other strains, 2 capsules/day; no placebo arm | 12 weeks | Lesion count changed in all 3 arms |
Questions people ask
Does acidophilus help with rosacea?
There's no trial to answer that. This review didn't find a single study — of any size or quality — that tested Lactobacillus acidophilus, alone or in a blend, in people with rosacea. Discussion of a broader gut-skin connection in rosacea exists in the scientific literature, but that's a hypothesis, not a clinical trial of this specific ingredient.
Will acidophilus help seborrheic dermatitis on the vulva?
No trial covers that question, at any body site. Vulvar skin symptoms have several possible causes — irritant contact dermatitis, a yeast infection, lichen sclerosus and seborrheic dermatitis can all look similar without an exam — so this is a case where getting a diagnosis matters more than a supplement search, and it's worth seeing a doctor rather than guessing.
Does acidophilus help with eczema?
The honest answer depends on which eczema question is being asked. A blend containing L. acidophilus AD031, given to pregnant women and their infants, was tied to fewer eczema cases in infants at family risk by age 1 — a prevention result, not a treatment for someone who already has it. Separately, two small trials of a specific heat-killed L. acidophilus strain (L-92) found lower disease-severity scores in adults who already had atopic dermatitis. Neither result says anything about children with existing eczema, or about a generic "acidophilus" capsule that isn't the L-92 strain or the AD031/BGN4/AD011 blend those trials used.
Does acidophilus help with acne?
One trial included it, as part of a three-strain blend, and the trial's design makes it hard to credit acidophilus specifically. Forty-five women with mild-to-moderate acne were split between a probiotic-blend-only group, an antibiotic (minocycline) group, and a combined group over 12 weeks; total lesion counts changed in all three groups. Because there was no placebo-only group, nothing here shows what the probiotic blend does compared with taking nothing — and the study used an antibiotic in two of its three arms, which this review reports only as a fact of the trial's design, not as a comparison of results.
When to talk to a doctor
Persistent or worsening rosacea, eczema, seborrheic dermatitis or acne — especially on the vulva, or anywhere a rash doesn't resolve or gets worse — is worth a dermatologist's or doctor's exam rather than a supplement search; several skin conditions look alike and are managed differently. Acidophilus is not a treatment for any of the skin conditions on this page, and nothing in the trials above supports using it as a substitute for a prescribed medication, a dermatology visit or medical advice. If you're pregnant, nursing, or considering a supplement for a child, that's a question for a doctor before starting anything.
Related reading: acidophilus: what the research does and doesn't show about diarrhea, constipation and other symptoms, acidophilus side effects, who shouldn't take acidophilus, and how to choose an acidophilus supplement.
Sources
- Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial A probiotic blend including L. acidophilus, given to pregnant women and continued after birth, was linked to a lower rate of eczema in their infants by age 1 (18% vs 40%) in a small trial — this tested prevention in at-risk infants, not treatment of an existing skin condition.
- Effects of oral administration of Lactobacillus acidophilus L-92 on the symptoms and serum cytokines of atopic dermatitis in Japanese adults: a double-blind, randomized, clinical trial In a small trial, adults with atopic dermatitis who took a heat-killed L. acidophilus strain (L-92) for 8 weeks had lower disease-severity scores than the placebo group.
- Efficacy of prolonged ingestion of Lactobacillus acidophilus L-92 in adult patients with atopic dermatitis A longer, 24-week trial of the same heat-killed L-92 strain found lower disease-severity scores in adults with atopic dermatitis versus placebo, with no adverse events reported.
- Prospective, randomized, open-label trial comparing the safety, efficacy, and tolerability of an acne treatment regimen with and without a probiotic supplement and minocycline in subjects with mild to moderate acne In a 12-week, open-label trial, 45 women with mild-to-moderate acne were split between a probiotic blend (including L. acidophilus), an antibiotic, and both together; with no placebo-only arm, the trial can't say how much of the probiotic-only group's change was the probiotic itself versus time.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.